Cognitive Training Intervention and Attitudes Towards Genetics
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Alabama at Birmingham
About this trial
A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.
Eligibility criteria
Qualifiers
≥ 21 years old at time of allogeneic HCT performed at UAB
Outpatient and between 3 and 6 months post HCT
English speaking
Possess access to an internet-connected home computer
Disqualifiers
History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
Participated in neuropsychological intervention within the past 6 months
History of color blindness
Trial design
Treatments tested in this trial
- Lumosity
- Lumosity (waitlist control)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov